Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Fiala, Mark A  [Clear All Filters]
2023
Slade M, Fiala MA, Kirchmeyer M, King J, Gao F, Schroeder MA, A Stewart K, Stockerl-Goldstein K, Chen C, Vij R. Continuous Elotuzumab, Pomalidomide and Dexamethasone Maintenance Following Second Autologous Transplant for Multiple Myeloma: Results of a Prospective, Phase 2 Multicenter Trial. Transplant Cell Ther. 2023.
2021
Xiang J, Shi M, Fiala MA, Gao F, Rettig MP, Uy GL, Schroeder MA, Weilbaecher KN, Stockerl-Goldstein K, Mollah S, et al. Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors. Blood Adv. 2021.
2018
Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Dávila J, Vij R, Fiala MA, Gozzetti A, Grzasko N, Milunovic V, et al. Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma. 2018:1-6.
2016
Fiala MA, Slade M, Wang S, Park S, DiPersio J, Stockerl-Goldstein K. The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation. Leuk Lymphoma. 2016:1-3.
Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, et al. Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation. Leuk Res. 2016;49:1-6.
2015
Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM. Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma. Leuk Lymphoma. 2015:1-29.